COI Disclosure

Disclosure of Conflict of Interest (COI) (related to your Abstract)

Presenting authors are required to report any financial relationship with any commercial entities or for-profit organizations related to the clinical research within the previous 12 months.
The definition of "clinical research" includes all phases of clinical trial and pre-clinical research.

At the time of abstract submission

If the authors have any commercial relationships relevant to the content of the abstract, they are required to report applicable COI to the secretariat.

At the time of presentation

The presenting author is required to disclose applicable COI by displaying a COI disclosure slide at the beginning of presentation slides (the slide after the title of presentation and the name of presenters) or at the end of a poster using samples as attached.

COI COI COI

Ethical Approval

In the case that a presentation theme relates to “Ethical guidelines for Clinical Research”, the approval of the Institutional Review Board (IRB) or the Ethical Review Board (ERB) is required. Please refer to the guideline of the Ministry of Education, Culture, Sports, Science and Technology website.
(http://www.lifescience.mext.go.jp/files/pdf/n1500_01.pdf)